Co2 Laser Cutter,Co2 Laser Engraver,80W Co2 Laser Engraver Cutter,Co2 Laser Engraving Cutting Machine Shandong Meiman Laser Technology Co., Ltd. , https://www.meimanlasers.com
The “Four-in-one†mass spectrometry detection technology independently developed by Guangdong Lianjie Detection Company has now obtained a number of international patents, which will provide a more accurate detection platform for the biotechnology industry.
The "4-in-1" mass spectrometry technology is to test the efficacy, bioavailability, pharmacology, and toxicology of a drug. It can quickly and accurately detect the concentration of a drug in human blood, and it can be used as a traditional drug. Compared with the experiment, it has the characteristics of short cycle, low cost and high precision.
Zhu Jianxiong, Chairman of Guangdong Lianjie Biotechnology Co., Ltd.: “This set of isotope labels is a bottleneck in the world. The reason why mass spectrometry cannot be shipped clinically is also one of the bottlenecks. In this regard, we applied for (international) patents last year. Can solve this problem completely, so our goal is to make the four-in-one mass spectrometer be able to do the same as the fool machine, can be shipped to the clinic quickly and easily and cheaply, this goal we have from research and development so far, It has basically reached this goal."
It is understood that Guangdong Lianjie Biotechnology Co., Ltd. is a branch of the United States Senior Biochemical Analysis Co., Ltd. established in Songshan Lake, mainly engaged in biotechnology testing, material structure analysis and other fields. Next, the company will continue to increase investment in R&D, and establish a common platform for biotechnology research and development and testing, which will lay the foundation for enterprises to achieve leap-forward development.
Zhu Jianxiong, chairman of Guangdong Lianjie Biotechnology Co., Ltd., said: “We plan to list the new three boards next year, and at the same time realize the A round of financing. After it is over, we plan to implement this project in five years or so, and we must promote it nationwide. ."
(Original title: Guangdong Enterprises Independently Developed "Four-in-One" Mass Spectrometer Detection Technology Obtained International Patent)
State-owned enterprises independently developed "four-in-one" mass spectrometry detection technology and obtained international patent
[China Instrument Network Instrument R&D] Recently, Guangdong Lianjie Testing Company has independently developed a “4-in-1†mass spectrometry detection technology that combines the efficacy, bioavailability, pharmacology, and toxicology of drugs to conduct experiments that are fast and accurate. The detection of the concentration of the drug in human blood has the characteristics of short cycle, low cost and high accuracy compared with traditional drug clinical experiments. At present, this technology has obtained a number of international patents and will provide a more accurate detection platform for the biotechnology industry.